Raymond James Financial
TDOC icon

Raymond James Financial’s Teladoc Health TDOC Stock Holding History

Raymond James Financial’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$187K Sell
34,241
-3,921
-10% -$22K ﹤0.01% 4904
2025
Q4 		$267K Buy
38,162
+9,674
+34% +$75.7K ﹤0.01% 4648
2025
Q3 		$220K Sell
28,488
-9,916
-26% -$77.4K ﹤0.01% 4580
2025
Q2 		$334K Sell
38,404
-5,600
-13% -$40.6K ﹤0.01% 4238
2025
Q1 		$350K Buy
44,004
+11,694
+36% +$118K ﹤0.01% 4124
2024
Q4 		$294K Buy
+32,310
New +$312K ﹤0.01% 4192

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's TDOC Position: Q1 2026 in Review

Raymond James Financial reduced its Teladoc Health (TDOC) stake by 10% in Q1 2026, selling an estimated $22K and leaving 34,241 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #4904.

Raymond James Financial first reported a position in TDOC in Q4 2024 and has held it in 6 quarters since. The position peaked at $350K in Q1 2025. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Raymond James Financial held 34,241 shares of Teladoc Health worth $187K as of Q1 2026.
  • Raymond James Financial sold 3,921 Teladoc Health shares in Q1 2026, an estimated $22K.
  • Teladoc Health made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4904 holding.
  • Raymond James Financial first reported a position in Teladoc Health in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Teladoc Health position peaked at $350K in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.